Israel
· Delayed Price · Currency is ILS · Price in ILA BioLight Life Sciences Statistics
Total Valuation
TLV:BOLT has a market cap or net worth of ILS 30.85 million. The enterprise value is 21.85 million.
| Market Cap | 30.85M |
| Enterprise Value | 21.85M |
Important Dates
The last earnings date was Saturday, March 22, 2025.
| Earnings Date | Mar 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:BOLT has 4.66 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.66M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 58.36% |
| Owned by Institutions (%) | 24.67% |
| Float | 187,375 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 140.89 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.06 |
| EV / Sales | 99.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.98 |
Financial Position
The company has a current ratio of 6.94, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.94 |
| Quick Ratio | 6.94 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.60% and return on invested capital (ROIC) is -20.49%.
| Return on Equity (ROE) | -27.60% |
| Return on Assets (ROA) | -18.71% |
| Return on Invested Capital (ROIC) | -20.49% |
| Return on Capital Employed (ROCE) | -31.56% |
| Revenue Per Employee | 54,750 |
| Profits Per Employee | -1.79M |
| Employee Count | 4 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.00% in the last 52 weeks. The beta is 0.56, so TLV:BOLT's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +56.00% |
| 50-Day Moving Average | 673.24 |
| 200-Day Moving Average | 531.88 |
| Relative Strength Index (RSI) | 42.58 |
| Average Volume (20 Days) | 316 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:BOLT had revenue of ILS 219,000 and -7.14 million in losses. Loss per share was -1.53.
| Revenue | 219,000 |
| Gross Profit | 219,000 |
| Operating Income | -10.12M |
| Pretax Income | -8.42M |
| Net Income | -7.14M |
| EBITDA | -9.52M |
| EBIT | -10.12M |
| Loss Per Share | -1.53 |
Balance Sheet
The company has 13.47 million in cash and 599,000 in debt, giving a net cash position of 12.87 million or 2.76 per share.
| Cash & Cash Equivalents | 13.47M |
| Total Debt | 599,000 |
| Net Cash | 12.87M |
| Net Cash Per Share | 2.76 |
| Equity (Book Value) | 30.74M |
| Book Value Per Share | 5.77 |
| Working Capital | 12.28M |
Cash Flow
In the last 12 months, operating cash flow was -10.99 million and capital expenditures -28,000, giving a free cash flow of -11.02 million.
| Operating Cash Flow | -10.99M |
| Capital Expenditures | -28,000 |
| Free Cash Flow | -11.02M |
| FCF Per Share | -2.37 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -4,619.63% |
| Pretax Margin | -3,846.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLV:BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | -0.29% |
| Earnings Yield | -23.15% |
| FCF Yield | -35.72% |
Stock Splits
The last stock split was on February 28, 2016. It was a reverse split with a ratio of 0.04.
| Last Split Date | Feb 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |